Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials-Reference-Cited by-同舟云学术

Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials

Published:2019-08-13 Issue:9 Volume:21 Page:1064-1078
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Ahmad Tariq¹²,Miller P. Elliott¹,McCullough Megan¹,Desai Nihar R.¹²,Riello Ralph¹,Psotka Mitchell³,Böhm Michael⁴,Allen Larry A.⁵,Teerlink John R.⁶,Rosano Giuseppe M.C.⁷,Lindenfeld Joann⁸

Affiliation:

1. Section of Cardiovascular Medicine New Haven CT USA

2. Center for Outcome Research & Evaluation (CORE)Yale University School of Medicine New Haven CT USA

3. Inova Heart & Vascular Institute Falls Church VA USA

4. Klinik für Innere Medizin IIIUniversitätsklinikum des Saarlandes Homburg Germany

5. Division of Cardiology, School of MedicineUniversity of Colorado Aurora CO USA

6. San Francisco Veterans Affairs Medical CenterUniversity of California San Francisco San Francisco CA USA

7. Cardiovascular and Cell Sciences Research InstituteSt George's University of London London UK

8. Vanderbilt Heart and Vascular Institute Nashville TN USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.1557

Reference102 articles.

1. Medical Therapy of Acute Myocardial Infarction by Application of Hemodynamic Subsets

2. Medical Therapy of Acute Myocardial Infarction by Application of Hemodynamic Subsets

3. On the mechanical factors which determine the output of the ventricles

4. The Use of Digoxin in Patients With Worsening Chronic Heart Failure

5. Cardiac inotropes: current agents and future directions

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calotropin attenuates ischemic heart failure after myocardial infarction by modulating SIRT1/FOXD3/SERCA2a pathway;Biomedicine & Pharmacotherapy;2024-10

2. Home inotrope therapy in chronic stimulant-induced cardiomyopathy: a case series;European Heart Journal - Case Reports;2024-08

3. Efficacy and Safety of Omecamtiv Mecarbil in Adult Patients with Heart Failure with Reduced Ejection Fraction;International Journal of Pharmacology;2024-08-01

4. Beyond quadruple therapy: the potential roles for ivabradine, vericiguat, and omecamtiv mecarbil in the therapeutic armamentarium;Heart Failure Reviews;2024-06-29

5. Challenging and target-based shifting strategies for heart failure treatment: An update from the last decades;Biochemical Pharmacology;2024-06